Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Comparison of capillary electrophoresis sequencing with the new CEQ 2000 DNA Analysis System to conventional gel based systems for HIV drug resistance analysis.

Merel P, Pellegrin I, Garrigue I, Caumont A, Schrive MH, Birac V, Bonot P, Fleury H.

J Virol Methods. 2001 Oct;98(1):9-16.

PMID:
11543879
2.

Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.

Muñoz M, Carmona R, Pérez-Alvarez L, Cilla G, Suarez MD, Delgado E, Contreras G, Corral J, de Goicoetxea MJ, Medrano L, Lezaún MJ, Nájera R; Spanish Group for Antiretroviral Resistance Studies in Basque Country.

J Clin Virol. 2005 Jul;33(3):224-9. Epub 2005 Jan 12.

PMID:
15911444
3.

Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.

Tsongalis GJ, Gleeson T, Rodina M, Anamani D, Ross J, Joanisse I, Tanimoto L, Ziermann R.

J Clin Virol. 2005 Dec;34(4):268-71.

PMID:
16286050
4.
5.

Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples.

Cunningham S, Ank B, Lewis D, Lu W, Wantman M, Dileanis JA, Jackson JB, Palumbo P, Krogstad P, Eshleman SH.

J Clin Microbiol. 2001 Apr;39(4):1254-7.

6.

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.

Bellocchi MC, Forbici F, Palombi L, Gori C, Coelho E, Svicher V, D'Arrigo R, Emberti-Gialloreti L, Ceffa S, Erba F, Marazzi MC, Silberstein FC, Perno CF.

J Med Virol. 2005 Aug;76(4):452-8.

PMID:
15977236
7.

Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase.

Koch N, Tamalet C, Tivoli N, Fantini J, Yahi N.

J Clin Virol. 2001 May;21(2):153-62.

PMID:
11378496
9.

Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection.

Re MC, Monari P, Bon I, Borderi M, Chiodo F; HIV-1 Emilia Romagna Infectious Disease Study Group.

Int J Antimicrob Agents. 2004 Feb;23(2):164-8.

PMID:
15013042
10.

Accuracy of the TRUGENE HIV-1 genotyping kit.

Grant RM, Kuritzkes DR, Johnson VA, Mellors JW, Sullivan JL, Swanstrom R, D'Aquila RT, Van Gorder M, Holodniy M, Lloyd Jr RM Jr, Reid C, Morgan GF, Winslow DL.

J Clin Microbiol. 2003 Apr;41(4):1586-93.

11.

Antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results.

Rodrigues R, Vazquez CM, Colares JK, Custodio RM, Bonásser Filho F, Souza Ldo R, Gianna MC, Marques CC, Brígido LF.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):97-102. Epub 2005 Apr 12.

12.

Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit.

Stelzl E, Pröll J, Bizon B, Niklas N, Danzer M, Hackl C, Stabentheiner S, Gabriel C, Kessler HH.

J Virol Methods. 2011 Dec;178(1-2):94-7. doi: 10.1016/j.jviromet.2011.08.020. Epub 2011 Aug 27.

PMID:
21907239
13.

Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods.

Erali M, Page S, Reimer LG, Hillyard DR.

J Clin Microbiol. 2001 Jun;39(6):2157-65.

14.

Evaluation of the LiPA HIV-1 RT assay version 1: comparison of sequence and hybridization based genotyping systems.

Stürmer M, Morgenstern B, Staszewski S, Doerr HW.

J Clin Virol. 2002 Dec;25 Suppl 3:S65-72.

PMID:
12467779
15.

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.

Saracino A, Gianotti N, Marangi M, Cibelli DC, Galli A, Punzi G, Monno L, Lazzarin A, Angarano G; Mutations, Salvage Study Group.

J Med Virol. 2008 Oct;80(10):1695-706. doi: 10.1002/jmv.21261.

PMID:
18712823
16.

A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.

Steegen K, Demecheleer E, De Cabooter N, Nges D, Temmerman M, Ndumbe P, Mandaliya K, Plum J, Verhofstede C.

J Virol Methods. 2006 May;133(2):137-45. Epub 2005 Dec 20.

PMID:
16375980
17.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
18.

Rates of transmission of antiretroviral drug resistant strains of HIV-1.

Ammaranond P, Cunningham P, Oelrichs R, Suzuki K, Harris C, Leas L, Grulich A, Cooper DA, Kelleher AD.

J Clin Virol. 2003 Feb;26(2):153-61. Review.

PMID:
12600647
19.

Predictors of the virological response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088).

Vray M, Meynard JL, Dalban C, Morand-Joubert L, Clavel F, Brun-Vézinet F, Peytavin G, Costagliola D, Girard PM; Narval Trial Group.

Antivir Ther. 2003 Oct;8(5):427-34.

PMID:
14640390
20.

Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.

Capiluppi B, Saracco A, Gianotti N, Mussini C, Butini L, Tomasoni L, De Gennaro M, Rizzolo L, Monolo G, Cargnel A, Moioli C, Arici C, Portelli V, Rizzardini G, Lazzarin A, Tambussi G.

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):73-8.

PMID:
12003179

Supplemental Content

Support Center